SNOA · Sonoma Pharmaceuticals, Inc.
$1.14
+0.00 (+0.00%)
At close · Jul 27
Market Cap
$5.46M
Shares
4.79M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-18 | — | |
| 10-K | 2026-06-16 | 2026-03-31 | |
| DEF 14A | 2026-05-05 | 2026-06-24 | |
| 8-K | 2026-04-30 | 2026-04-24 | |
| 8-K | 2026-04-09 | 2026-04-08 | |
| 10-Q | 2026-02-10 | 2025-12-31 | |
| 8-K | 2026-01-28 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-02 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-10-23 | 2025-10-18 | |
| 8-K | 2025-10-09 | 2025-10-03 | |
| 8-K | 2025-09-29 | — | |
| 8-K | 2025-09-26 | — | |
| 8-K | 2025-08-29 | 2025-08-27 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| DEF 14A | 2025-07-11 | 2025-08-27 | |
| 10-K | 2025-06-17 | 2025-03-31 | |
| 8-K | 2025-04-28 | — | |
| 8-K | 2025-04-07 | — | |
| 8-K | 2025-03-25 | 2025-03-21 | |
| 10-Q | 2025-02-05 | 2024-12-31 | |
| 8-K | 2025-01-30 | 2025-01-29 | |
| 8-K | 2025-01-03 | 2025-01-02 | |
| 8-K | 2024-11-21 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-22 | 2024-10-17 | |
| 8-K | 2024-09-20 | — | |
| 8-K | 2024-08-28 | 2024-08-23 | |
| 8-K | 2024-08-23 | 2024-08-22 | |
| 8-K | 2024-08-21 | 2024-08-19 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| DEF 14A | 2024-07-01 | 2024-08-14 | |
| 8-K | 2024-06-27 | — | |
| 10-K | 2024-06-17 | 2024-03-31 | |
| 8-K | 2024-04-09 | — | |
| 8-K | 2024-04-02 | — | |
| 8-K | 2024-03-22 | 2024-03-21 | |
| 8-K | 2024-03-08 | — | |
| 10-Q | 2024-02-08 | 2023-12-31 | |
| 8-K | 2024-01-10 | — | |
| 8-K | 2024-01-09 | 2024-01-05 | |
| 8-K | 2023-12-29 | — | |
| 8-K | 2023-12-18 | 2023-12-15 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-11 | — | |
| 8-K/A | 2023-10-11 | — | |
| 8-K | 2023-09-28 | 2023-09-22 | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| DEF 14A | 2023-07-27 | 2023-09-14 |
Showing 1–50 of 106 filings